NGO Funds India

DBT-BIRAC Joint Call for Proposals on Bio AI for Fostering High Performance Biomanufacturing under BioE3 Policy

Department of Biotechnology (DBT) · Central government · Verified 3 August 2026

A joint call funds Bio AI hubs in biomanufacturing under BioE3 for startups, LLPs, and academic SIROs.

Closed. Applications closed on 30 June 2026. The details below describe the most recent cycle.

Key facts

Grant size
Not specified
Funding type
Grant
Deadline
30 June 2026

About this program

The DBT-BIRAC Joint Call for Proposals on Bio AI seeks to merge artificial intelligence with biotechnology to advance high-performance biomanufacturing, in line with India's BioE3 (Biotechnology for Economy, Environment and Employment) policy. Bio-AI is framed as a key driver for data-led, programmatic research that aims to generate novel research leads with substantial relevance to Health, Agriculture, and Environment. The call supports the creation of Bio-AI Hubs—interdisciplinary, interinstitutional partnerships anchored by organisations with proven expertise in AI/ML and backed by strong computational infrastructure. These hubs function as shared DBTL (Design-Build-Test-Learn) facilities under a Public-Private Partnership model, with startups and SMEs acting as spokes that contribute to each hub's research and innovation ecosystem.

Bio-AI Hubs are expected to build AI-guided closed-loop platforms that integrate predictions, experiments, and analyses in a continuous positive feedback cycle, accelerating scientific discovery, refining bioprocesses, and enhancing decision-making at scale. The call spans five thematic areas: Biomolecular Design, covering novel proteins, enzymes, bio-nanomachines, and next-generation antibodies; Sustainable Agriculture, addressing drought-resistant crops, AI-powered disease sensing, and dairy genomics; Synthetic Biology, focusing on metabolic pathway optimisation, strain engineering, and environmental biosensors; Ayurveda, involving AI-driven pharmacogenomics, herb-drug interaction analysis, and plant-based drug discovery; and Genome Diagnostics, which includes AI risk prediction for diabetes and cardiovascular diseases, cancer biomarkers, single-cell genomics, and neurodegenerative disorder stratification. Proposals are assessed on a rolling basis. Organisations selected through this process gain access to state-of-the-art biomanufacturing facilities and the wider DBT-BIRAC network, enabling high-impact collaboration with leading institutions and industry partners across India.

Who can apply

Eligible organisation types
All nonprofit forms
12A registration
Not specified
80G registration
Not specified
CSR-1 registration
Not specified
FCRA registration
Not specified
NGO Darpan ID
Not specified
Where the NGO may be based
Not restricted
  • Companies incorporated under the Companies Act 2013, startups, and Limited Liability Partnerships registered under the LLP Act 2008 are eligible.
  • Academic institutions, universities, societies, trusts, NGOs, and foundations recognised as Scientific and Industrial Research Organisations (SIRO) may also apply.
  • Startups and SMEs may participate as spokes within the hub model, contributing specialised capabilities while using the hub's shared infrastructure, mentorship, and access to advanced computational and biomanufacturing tools.
  • Only Indian entities are eligible.
  • Proposals are evaluated solely on scientific merit, feasibility, and alignment with BioE3 policy priorities.

How to apply

Submit proposals exclusively through the online portal at www.birac.nic.in. Hard-copy submissions will not be accepted under any circumstances. Applications are reviewed on a rolling basis at regular intervals during the open call period. The final deadline is June 30, 2026, at midnight.

Apply on the funder's site

How applications are assessed

Proposals are reviewed at regular intervals on a rolling schedule. Evaluation considers only scientific merit, feasibility, and how well the proposal fits BioE3 policy priorities.

Frequently asked questions

Who is eligible to apply for the DBT-BIRAC Bio AI call?

Eligible applicants are Indian entities, including companies registered under the Companies Act 2013, startups, LLPs under the LLP Act 2008, academic institutions, universities, societies, trusts, NGOs, and DSIR-recognised research organisations. Startups and SMEs may take part as spokes within a hub model.

What are the five thematic areas covered?

The programme funds research across five areas: biomolecular design (novel proteins, enzymes, next-gen antibodies), sustainable agriculture (drought-resistant crops, AI-powered disease sensing, dairy genomics), synthetic biology (metabolic pathway optimisation, strain engineering), Ayurveda (AI-driven pharmacogenomics, plant-based drug discovery), and genome diagnostics (cancer biomarkers, neurodegenerative disorder stratification).

How much funding is available?

The call does not specify a fixed per-project grant amount. Funding depends on the scope of the proposed Bio-AI Hub or spoke participation, and is assessed by DBT-BIRAC on scientific merit and feasibility.

Is equity taken, and is this repayable?

The grant is non-repayable and no equity is taken. It is a government research and development grant provided under India's BioE3 policy framework.

Can a startup participate without being the lead hub organization?

Yes. Startups and SMEs may join as spoke organisations, offering specialised skills while using the hub’s shared facilities, guidance, and advanced computational and biomanufacturing equipment.

What is the application deadline and how should proposals be submitted?

The submission deadline is 30 June 2026, at midnight. Proposals must be submitted online exclusively at www.birac.nic.in; hard copies are not accepted under any circumstances.

Focus areas

  • Health Pharma Biotech
  • Agri Food Rural
  • Climate Energy Ev
  • Grant
  • Biotech
  • Ai Ml
  • Deeptech
  • Healthtech
  • Agritech
  • Sustainability
  • Diagnostics
  • Pan India
  • Birac

Details last verified on 3 August 2026. Source: the funder's published information.

GrantCentral governmentOpen for applications

MCL Seed Grant 2026

NIT Rourkela

MCL and FTBI NIT Rourkela's seed grant programme funds innovative technology startups incubated at FTBI with up to ₹3 lakh.

Grant size
Up to ₹3 lakh
Deadline
20 August 2026
Time left
4 days

Seed Funding · Csr Funding · Innovation · Deeptech

GrantNetwork or intermediaryOpen for applications

SheConnects Digital Accelerator India 2026 (Round 2)

Reliance Foundation

Grants and support for not-for-profits scaling proven solutions to advance women's digital inclusion across India.

Grant size
₹85 lakh – ₹4.2 crore
Deadline
4 September 2026
Time left
19 days

Fintech · Health Pharma Biotech · Agri Food Rural · Edtech

PrizeForeign foundationOpen for applications

The Wellcome Prize for Mental Health Science with Nature

Wellcome

The Wellcome-Nature Mental Health Prize funds groundbreaking mental health science, awarding up to ₹9.52 crore to the winner and ₹2.38 crore to finalists, plus visibility and support.

Grant size
₹2.38 crore – ₹9.53 crore
Deadline
15 September 2026
Time left
29 days

Health Pharma Biotech · Social Impact · Mental Health · Science